Skip to content

Effect of Mode of Femoral Nerve Analgesia on Quadriceps Muscle Strength

Effect of Continuous Femoral Analgesia on Quadriceps Muscle Strength-0.2% Ropivacaine Continuous Infusion Versus Patient Controlled Femoral Analgesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02007850
Enrollment
36
Registered
2013-12-11
Start date
2014-02-28
Completion date
2015-07-31
Last updated
2014-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Weakness

Keywords

continuous femoral nerve block, knee arthroplasty, quadriceps muscle strength

Brief summary

Quadriceps muscle strength is an important determinant of quality of recovery in elderly patients after total knee arthroplasty. We try to compare the quadriceps muscle strength change between 0.2 % ropivacaine continuous fixed femoral infusion and patient controlled femoral analgesia group.

Detailed description

Continuous femoral nerve analgesia technique is relatively safe, can be easily trained, and reduces significantly intravenous opioid consumption. These favorable features make it standard treatment option for postoperative knee pain. However, direct perineural local anesthetic effect is not only confined into pain fiber, but, the other sensory and motor nerve fibers. Therefore, unwanted motor weakness is accompanied. Quadriceps muscle strength, which is important determinant of physical function after knee arthroplasty, can be influenced in continuous femoral nerve block. Various local anesthetic infusion techniques have been suggested to minimize the change of quadriceps muscle strength. Decreasing local anesthetic concentrations affect not only degree of muscle weakness, but also reduces the quality of pain control. Different anatomic location of catheter tip, considering motor fiber in posterior part of femoral nerve, could not reduce motor weakness. In a study with continuous popliteal-sciatic nerve blocks after hallux valgus repair, repeated bolus administration seems to be more effective method for pain control without concurrent motor impairment. However, another study with continuous femoral nerve block in healthy volunteers, hourly repeated bolus dose of 5 ml of 0.1% ropivacaine failed to spare motor block. Previously, our institution standard technique is fixed continuous infusion of 0.2% ropivacaine and concomitant intravenous patient controlled fentanyl. Because physical therapy of our institution, usually starts with the 2nd day of operation, so, we assume that continuous fixed infusion may result in more drug accumulation near nerve fiber. So, patient controlled mode of femoral analgesia could be better choice for initiation of physical therapy. At the same time, comparison between patient controlled analgesia and continuous infusion is not fully elucidated until recently. Therefore, in this study, we try to compare quadriceps muscle strength change between continuous infusion and patient controlled femoral analgesia in patients undergoing total knee replacement arthroplasty. Secondary outcomes include sensory effect in femoral nerve distribution, pain scores, iv fentanyl consumption, and other adverse effects.

Interventions

DRUGropivacaine

Patients receive 15 ml of 0.25% ropivacaine pre-operatively through femoral block catheter, followed by 0.2% ropivacaine continuous mode or patient controlled mode for 2 days after surgery

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* \> 21, or \< 80 years old- men and women * primary, unilateral total knee replacement surgery * spinal anesthesia

Exclusion criteria

* general anesthesia * secondary knee replacement surgery * patient refusal for continuous femoral nerve analgesia technique * abnormal coagulation profile, e.g. Prothrombin time international normalized ratio \> 1.5, activated partial thrombin time \> 50 sec * within 5 days after termination oral antiplatelet agent * Body mass index\>45 * impaired renal function * infection near femoral area * previous injury near femoral area * neurologic dysfunction in lower limb * previous adverse drug reaction for local anesthetics * American society of anesthesiologists (ASA) class III, iV or V

Design outcomes

Primary

MeasureTime frameDescription
Change of quadriceps muscle strengthBaseline, Postoperative 2nd daymaximum voluntary isometric contraction of quadriceps femoris with hand held manometry

Secondary

MeasureTime frameDescription
sensory changes in femoral nerve distributionpostoperative 2 daytolerance to transcutaneous electrical stimulation
pain scorespostoperative 1 dayverbal numeric pain scale (0-100) resting/dynamic
intravenous fentanyl consumptionpostoperative 2 daycumulative fentanyl consumption on postoperative 2 day

Countries

South Korea

Contacts

Primary ContactHae Wone Chang, M.D
chelenh@gmail.com82-031-787-7499

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026